A healthcare provider may be able to prescribe additional medication or therapies to help reduce the appearance of dark areas
An important consideration is that PET studies have shown increased TSPO radioligand uptake in many different neurological and psychiatric conditions, such as autism, traumatic brain injury, major depression, bipolar disorder, Parkinson's disease, chronic pain, multiple sclerosis, and schizophrenia [e.g., (6266)]
Figure 7: Recovery of motor functioning in groups of mice administered MSC, G-CSK, and Dihexa, determined by walking track foot prints of normal and sciatic nerve resected limbs
PTH and the regulation of mesenchymal cells within the bone marrow niche